1. Home
  2. OGI vs IMUX Comparison

OGI vs IMUX Comparison

Compare OGI & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Organigram Holdings Inc.

OGI

Organigram Holdings Inc.

HOLD

Current Price

$1.11

Market Cap

171.3M

Sector

Health Care

ML Signal

HOLD

Logo Immunic Inc.

IMUX

Immunic Inc.

HOLD

Current Price

$9.32

Market Cap

155.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OGI
IMUX
Founded
2013
2016
Country
Canada
United States
Employees
N/A
66
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
171.3M
155.8M
IPO Year
2015
2013

Fundamental Metrics

Financial Performance
Metric
OGI
IMUX
Price
$1.11
$9.32
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $36.00
AVG Volume (30 Days)
★ 507.1K
344.5K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 38.00
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$20.10
N/A
Revenue Next Year
$13.92
N/A
P/E Ratio
$13.91
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.85
$0.51
52 Week High
$2.24
$17.43

Technical Indicators

Market Signals
Indicator
OGI
IMUX
Relative Strength Index (RSI) 48.30 26.23
Support Level $1.03 $0.78
Resistance Level $1.21 $15.82
Average True Range (ATR) 0.04 0.70
MACD -0.00 -0.19
Stochastic Oscillator 58.42 5.67

Price Performance

Historical Comparison
OGI
IMUX

About OGI Organigram Holdings Inc.

Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. It operates in one segment which is Life science segment.

Share on Social Networks: